MANE - Veradermics, Inc

Insider Purchase by Suvretta Capital Management, LLC (Dir, 10%)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

2 weeks ago, Suvretta Capital Management, LLC, serving as Dir, 10% owner at Veradermics, Inc (MANE), purchased 282,674 shares at $37.30 per share, for a total transaction value of $10,542,478.00. Following this transaction, Suvretta Capital Management, LLC now holds 520,453 shares of MANE.

This purchase represents a 119.00% increase in Suvretta Capital Management, LLC's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, February 4, 2026 and publicly disclosed via SEC Form 4 filing on Monday, February 9, 2026, 5 days after the trade was made.

Suvretta Capital Management, LLC

Suvretta Capital Management, LLC

Dir, 10%

Suvretta Capital Management, LLC is a New York-based investment management firm founded in 2011 by Aaron Cowen, specializing in long/short equity strategies.[[1]](https://rocketreach.co/suvretta-capital-management-llc-profile_b7ce5552c15e34b1)[[2]](https://www.suvcap.com) The firm manages three primary strategies: a generalist long/short equity approach launched in September 2012 under Portfolio Manager Aaron Cowen, and two healthcare-focused strategies, Averill (started March 2020) and Averill Madison (launched November 2022), both led by Portfolio Manager Kishen Mehta.[[1]](https://rocketreach.co/suvretta-capital-management-llc-profile_b7ce5552c15e34b1)[[2]](https://www.suvcap.com) Headquartered at 540 Madison Avenue, 7th Floor, New York, NY, Suvretta Capital employs approximately 27-32 professionals and reported $13.8 million in revenue in 2024.[[1]](https://rocketreach.co/suvretta-capital-management-llc-profile_b7ce5552c15e34b1)[[3]](https://www.zoominfo.com/c/suvretta-capital-management-llc/374943810) As a registered investment adviser with the SEC (CRD #165153), the firm oversees significant assets, with recent 13F filings showing a portfolio market value of $3.32 billion as of June 30, 2025, including healthcare holdings like ARQT and ETNB.[[4]](https://whalewisdom.com/filer/suvretta-capital-management-llc)[[5]](https://adviserinfo.sec.gov/firm/summary/165153) Suvretta has acted as a corporate insider (Dir, 10%) in recent trades involving Benitec Biopharma Inc. (BNTC).[user_query]

View full insider profile →

Trade Price

$37.30

Quantity

282,674

Total Value

$10,542,478.00

Shares Owned

520,453

Trade Date

Wednesday, February 4, 2026

18 days ago

SEC Filing Date

Monday, February 9, 2026

Filed 5 days after trade

About Veradermics, Inc

Company Overview

No company information available
View news mentioning MANE

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/3843051

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime